Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Functional response of novel bioprotective poloxamer-structured vesicles on inflamed skin

  • Caddeo, C.
  • Manca, M.L.
  • Matos, Maria
  • Gutierrez, Gemma
  • Díez-Sales, Octavio
  • Esteban Peris, J.
  • Usach, Iris
  • Fernandez-Busquets, X.
  • Fadda, A.M.
  • Manconi, Maria
[EN] Resveratrol and gallic acid, a lipophilic and a hydrophilic phenol, were co-loaded in innovative, biocompatible nanovesicles conceived for ensuring the protection of the skin from oxidative-and inflammatory-related affections. The basic vesicles, liposomes and glycerosomes, were produced by a simple, one-step method involving the dispersion of phospholipid and phenols in water or water/glycerol blend, respectively. Liposomes and glycerosomes were modified by the addition of poloxamer, a stabilizer and viscosity enhancer, thus obtaining viscous or semisolid dispersions of structured vesicles. The vesicles were spherical, unilamellar and small in size (similar to 70 nm in diameter). The superior ability of the poloxamer-structured vesicles to promote the accumulation of both phenols in the skin was demonstrated, as well as their low toxicity and great ability to protect fibroblasts from chemically-induced oxidative damage. The in vivo administration of the vesicular phenols on TPA (phorbol ester)-exposed skin led to a significant reduction of oedema and leukocyte infiltration. (C) 2017 Elsevier Inc. All rights reserved., This work was partially supported by grants BIO2014-52872-R (Ministerio de Economia y Competitividad, Spain), which included FEDER funds, and 2014-SGR-938 (Generalitat de Catalunya, Spain).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

What makes a protein sequence a prion ?

  • Sabaté Lagunas, Raimon|||0000-0003-3894-2362
  • Rousseau, Frederic
  • Schymkowitz, Joost
  • Ventura, Salvador|||0000-0002-9652-6351
Typical amyloid diseases such as Alzheimer's and Parkinson's were thought to exclusively result from de novo aggregation, but recently it was shown that amyloids formed in one cell can cross-seed aggregation in other cells, following a prion-like mechanism. Despite the large experimental effort devoted to understanding the phenomenon of prion transmissibility, it is still poorly understood how this property is encoded in the primary sequence. In many cases, prion structural conversion is driven by the presence of relatively large glutamine/asparagine (Q/N) enriched segments. Several studies suggest that it is the amino acid composition of these regions rather than their specific sequence that accounts for their priogenicity. However, our analysis indicates that it is instead the presence and potency of specific short amyloid-prone sequences that occur within intrinsically disordered Q/N-rich regions that determine their prion behaviour, modulated by the structural and compositional context. This provides a basis for the accurate identification and evaluation of prion candidate sequences in proteomes in the context of a unified framework for amyloid formation and prion propagation. Protein conformational disorders include several neurodegenerative diseases. These pathologies are initiated by conformational changes in specific polypeptides that, in many cases, result in their spontaneous self-assembly to form toxic amyloids. Prions are a subclass of amyloids with the ability to propagate in vivo, thus becoming infectious. Previous work with yeast prions has provided tremendous insight into prion propagation mechanism. These proteins contain glutamine/asparagine (Q/N) enriched prion forming domains (PFDs), which are both necessary and sufficient for propagation. We found that these domains include specific short amyloid-prone sequences, which are likely able to trigger the amyloid conversion of the complete prion protein. The amyloid potency of these short segments suffices to discriminate with high accuracy between Q/N rich domains with and without prion activity. Our data suggest a model for prions where a classical amyloid core is embedded in a sequence context that reduces the amyloid nucleation potential, resulting in sequences that are strongly dependent on seeding. This model should allow the identification of prion-like proteins in the human proteome and prediction of the deleterious effects of genetic mutations occurring in these particular proteins.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Possible roles of amyloids in malaria pathophysiology

  • Moles, Ernest
  • Valle Delgado, Juan José
  • Urbán, Patricia
  • Azcárate, Isabel G.
  • Bautista, José M.|||0000-0001-8926-881X
  • Selva, Javier
  • Egea, Gustavo|||0000-0001-5242-150X
  • Ventura, Salvador|||0000-0002-9652-6351
  • Fernández Busquets, Xavier|||0000-0002-4622-9631
The main therapeutic and prophylactic tools against malaria have been locked for more than a century in the classical approaches of using drugs targeting metabolic processes of the causing agent, the protist Plasmodium spp., and of designing vaccines against chosen antigens found on the parasite's surface. Given the extraordinary resources exhibited by Plasmodium to escape these traditional strategies, which have not been able to free humankind from the scourge of malaria despite much effort invested in them, new concepts have to be explored in order to advance toward eradication of the disease. In this context, amyloid-forming proteins and peptides found in the proteome of the pathogen should perhaps cease being regarded as mere anomalous molecules. Their likely functionality in the pathophysiology of Plasmodium calls for attention being paid to them as a possible Achilles' heel of malaria. Here we will give an overview of Plasmodium-encoded amyloid-forming polypeptides as potential therapeutic targets and toxic elements, particularly in relation to cerebral malaria and the blood-brain barrier function. We will also discuss the recent finding that the genome of the parasite contains an astonishingly high proportion of prionogenic domains.